Calyxha Overview
- Founded
-
2019
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Seed
- Investors
-
5
Calyxha General Information
Description
Operator of a biotech company based in Vienna, Austria. The company develops novel therapies targeting tissue degeneration that is the fundamental underlying cause of major human diseases, providing the health industry with a drug for neurodegenerative diseases.
Contact Information
Website
www.calyxha.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- Karl-Farkas-Gasse 22
- Vienna, 1030
- Austria
+43 01 00000000000
Calyxha Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 04-Mar-2020 | Completed | Pre-Clinical Trials |
Calyxha Executive Team (5)
Calyxha Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Calyxha Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| ARAX Capital Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Kinled Holding | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Life Link Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Olipan Investments | Venture Capital | Minority | 000 0000 | 000000 0 | |
| The Blom Family Office | Family Office | Minority | 000 0000 | 000000 0 |